DF Dent & Co’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

DF Dent & Co’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,111	Closed	-$8.8K	–	269
2024 Q1	$8.8K	Buy	+1,111	New	+$8.34K	﹤0.01%	265
2023 Q4	–	Sell	-1,111	Closed	-$20.8K	–	273
2023 Q3	$20.8K	Hold	1,111	–	–	﹤0.01%	254
2023 Q2	$31.6K	Buy	+1,111	New	+$44.3K	﹤0.01%	254
2022 Q2	–	Sell	-1,111	Closed	-$107K	–	260
2022 Q1	$107K	Buy	+1,111	New	+$168K	﹤0.01%	252

Other funds holding TBIO

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DWS

Dynamic Wealth Strategies Granite Bay, California $188M AUM 18.55% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

DF Dent & Co's TBIO Position: Q2 2024 in Review

DF Dent & Co sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2024, closing a stake of 1,111 shares — an estimated $8.8K sold.

DF Dent & Co first reported a position in TBIO in Q1 2022 and held it in 4 quarters. The position peaked at $107K in Q1 2022. 10 funds tracked by Wall St. Rank hold TBIO as of Q2 2024.

DF Dent & Co reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
DF Dent & Co sold 1,111 Telesis Bio, Inc. Common Stock shares in Q2 2024, an estimated $8.8K.
DF Dent & Co first reported a position in Telesis Bio, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
DF Dent & Co's Telesis Bio, Inc. Common Stock position peaked at $107K in Q1 2022.
10 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2024.

Based on DF Dent & Co's 13F filing for Q2 2024, filed 14 Aug 2024.